Congratulations to Natalie Miller

Congratulations to Natalie Miller, UW MSTP, Pathology and the Nghiem laboratory on their successful phase II treatment of Merkel Cell carcinoma patients with immunotherapy.  Natalie Miller is a fourth year Molecular Basis of Disease (MBD) Ph.D. student in the Nghiem laboratory,

Read all about their work in The New England Journal of Medicine.   The original article, A PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma, can be accessed through the provided link.

Read the original, published article in The New England Journal of Medicine here.